Gabapentin Dementia Lawsuit in New York

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Written By
People's Justice Legal Research Team

Statute of Limitations

New York: 3 years for personal injury (CPLR § 214). Discovery rule applies — limitations begin when the plaintiff discovers or should have discovered the injury and its cause. New York recognizes medical monitoring claims for at-risk populations.

3 years from discovery of injury; medical monitoring available pre-diagnosis

Filing Venue

Where to File in New York

Pfizer is headquartered at 66 Hudson Boulevard, Manhattan, within the Southern District of New York, providing strong personal jurisdiction. SDNY has extensive pharmaceutical MDL experience. New York state courts offer coordination through mass tort management programs. New York does not cap compensatory damages in product liability cases. The state's recognition of medical monitoring claims allows gabapentin users who have not yet developed dementia to seek ongoing cognitive screening costs. New York follows pure comparative fault.

New York Data

Exposure in New York

Source: IQVIA / NY I-STOP PDMP data

Source: Pfizer SEC filings / corporate records

Source: NY case law / Caronia v. Philip Morris (2d Cir.)

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Back to Gabapentin Dementia Lawsuit Lawsuit Overview